| Cell Line Identifier | Alternative Names | Maintainer | Producer | Parental Cell Type | Tissue of Origin | Disease as reported | Modified? | Curation Status | Related Lines |
|---|---|---|---|---|---|---|---|---|---|
| AIBNe001-A | MEL1(AAVS1::tetON-fastFUCCI) | Australian Institute for Bioengineering and Nanotechnology | Australian Institute for Bioengineering and Nanotechnology | — | — | — | False | Not yet reviewed by Australian Stem Cell Registry | — |
| AIBNi001-A | GENIE 1 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi002-A | GENIE 38 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi003-A | GENIE 68 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi004-A | GENIE 69 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi005-A | GENIE 70 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi006-A | GENIE 74 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi007-A | GENIE 11 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi008-A | GENIE 29 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi009-A | GENIE 49 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi010-A | GENIE 75 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi011-A | GENIE 81 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi012-A | GENIE 116 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | epilepsy | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi013-A | hONS-derived Control iPSC; ONS-derived Control iPSC; Control HL iPSC | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | olfactory neurosphere cell line | — | — | False | Reviewed by Australian Stem Cell Registry | — |
| AIBNi014-A | hONS-derived A-T iPSC; ONS-derived A-T iPSC; A-T HL iPSC | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | olfactory neurosphere cell line | — | ataxia telangiectasia | False | Flagged for further review | — |
| AIBNi015-A | SPG1-AU01C15 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | fibroblast | — | hereditary spastic paraplegia 56 | False | Flagged for further review | — |
| AIBNi016-A | SPG2-S376C1 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | hereditary spastic paraplegia 56 | False | Flagged for further review | — |
| AIBNi017-A | SPGh1-S075mC2 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | — | False | Flagged for further review | — |
| AIBNi018-A | SPGh2-S964pC6 | Ernst Wolvetang | Australian Institute for Bioengineering and Nanotechnology | peripheral blood mononuclear cell | — | — | False | Flagged for further review | — |
| CDIi100-A-1 | FI.PPMI_42378(SNCA.A53T.11555.104).AAVS1::CAGG-iM-jRCaMP1b | — | The Florey Institute of Neuroscience and Mental Health | — | — | — | False | Not yet reviewed by Australian Stem Cell Registry | — |
| CIAUi001-A | AOY7 | — | Centenary Institute of Cancer Medicine and Cell Biology | — | — | — | False | Reviewed by Australian Stem Cell Registry | — |
| CIAUi002-A | UBC3-A2 | Centenary Institute of Cancer Medicine and Cell Biology | Centenary Institute of Cancer Medicine and Cell Biology | — | — | — | False | Reviewed by Australian Stem Cell Registry | — |
| CIAUi002-B | UBC3-U | — | Centenary Institute of Cancer Medicine and Cell Biology | — | — | — | False | Reviewed by Australian Stem Cell Registry | — |
| CIAUi002-C | UBC3 M1 | Centenary Institute of Cancer Medicine and Cell Biology | Centenary Institute of Cancer Medicine and Cell Biology | peripheral blood mononuclear cell | — | recurrent ventricular fibrillation, nonischemic cardiomyopathy, conduction disease | False | Reviewed by Australian Stem Cell Registry | — |
| CIAUi003-A | MCCIi005-A-1; BFC4 | — | Centenary Institute of Cancer Medicine and Cell Biology | peripheral blood mononuclear cell | — | catecholaminergic polymorphic ventricular tachycardia | False | Flagged for further review | — |